相关实验视频

Updated: Jul 7, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K

在STAT1小鼠中,通过新型人类单克隆抗体对致命的HAdV-4挑战进行保护

Xinyi Zhang1,2, Zhongge Zhu3, Peijie Zhai1,2

  • 1College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.

Frontiers in immunology
|July 4, 2025
PubMed
概括

人类腺病毒血清型4 (HAdV-4) 导致严重的呼吸系统疾病. 研究人员开发了一种单克隆抗体 (mAb) 2CF4,在临床前模型中有效中和HAdV-4,提供了潜在的新治疗方法.

关键词:
在 TRIM2121 中.人类腺病毒血清型4中和单克隆抗体的中和性抗体在stat1-/-转基因小鼠中.结构生物学结构生物学

更多相关视频

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

10.6K
Influenza A Virus Studies in a Mouse Model of Infection10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

28.8K

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...